Immunovant, Inc.
IMVT
$15.08
$0.191.28%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.95% | 12.37% | -45.77% | 75.21% | 69.72% |
| Total Receivables | -19.90% | -54.37% | 116.13% | 32.02% | 193.68% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 91.23% | 105.53% | 89.43% | 64.19% | 38.44% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 10.65% | 15.30% | -41.96% | 74.25% | 68.29% |
|
|
|||||
| Total Current Assets | 10.65% | 15.30% | -41.96% | 74.25% | 68.29% |
| Net Property, Plant & Equipment | 16.80% | 58.32% | 15.52% | -19.82% | -47.72% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 12.17% | 16.49% | -40.83% | 76.57% | 67.89% |
|
|
|||||
| Total Accounts Payable | -28.93% | 146.76% | 406.80% | 175.96% | -58.29% |
| Total Accrued Expenses | 32.86% | 22.88% | 73.84% | 42.77% | 41.43% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -28.99% | -92.48% | -92.35% | -92.49% |
| Total Finance Division Other Current Liabilities | -- | 1,720.00% | -- | -- | -- |
| Total Other Current Liabilities | -- | 1,720.00% | -- | -- | -- |
| Total Current Liabilities | 17.51% | 41.49% | 112.81% | 65.56% | -12.34% |
|
|
|||||
| Total Current Liabilities | 17.51% | 41.49% | 112.81% | 65.56% | -12.34% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 17.51% | 41.49% | 112.81% | 65.56% | -12.34% |
|
|
|||||
| Common Stock & APIC | 35.12% | 34.96% | 3.70% | 54.60% | 54.93% |
| Retained Earnings | -49.00% | -50.12% | -51.00% | -46.21% | -42.57% |
| Treasury Stock & Other | -4.56% | -23.53% | 513.17% | 272.32% | 212.71% |
| Total Common Equity | 11.73% | 14.52% | -48.09% | 78.33% | 81.64% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 11.73% | 14.52% | -48.09% | 78.33% | 81.64% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 11.73% | 14.52% | -48.09% | 78.33% | 81.64% |
|
|
|||||